These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32342297)

  • 1. ASO Author Reflections: Gene Signature Generated from Tumor Budding-A New Molecular Marker of Recurrence Risk.
    Shinto E; Yoshida Y; Ueno H
    Ann Surg Oncol; 2020 Oct; 27(10):4055-4056. PubMed ID: 32342297
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Practical Utility of Molecular Budding Signature-An Objective Gene Classification System as a Marker of Recurrence Risk.
    Shinto E
    Ann Surg Oncol; 2023 Aug; 30(8):5248-5249. PubMed ID: 37219653
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: BRCA Mutation Status for Personalizing Management of Recurrent Ovarian Cancer-A Multicenter Study.
    Fagotti A
    Ann Surg Oncol; 2018 Nov; 25(12):3709-3710. PubMed ID: 30178392
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Pancreatic Neuroendocrine Tumor Recurrence and Survival Predicted by Ki67.
    Nieveen van Dijkum EJM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):531-532. PubMed ID: 30519760
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Can We Predict an Unsalvageable Recurrence Following Colorectal Liver Metastasectomy?
    Okuno M; Conrad C
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):549-550. PubMed ID: 30565037
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Prognostic Impact of Budding Grade on Patients with Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
    Noro T
    Ann Surg Oncol; 2020 Dec; 27(13):5208. PubMed ID: 32770295
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Tumor Location Affects Local Recurrence in Rectal Cancer.
    Franz C; Kulu Y
    Ann Surg Oncol; 2020 Feb; 27(2):439. PubMed ID: 31673942
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemia Relapse-Associated Mutation of NT5C2 Gene is Rare in de Novo Acute Leukemias and Solid Tumors.
    Oh HR; Choi YJ; Yoo NJ; Lee SH
    Pathol Oncol Res; 2016 Jan; 22(1):223-4. PubMed ID: 26259531
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Defining Oligometastatic Recurrence in Biliary Tract Cancer.
    Morino K; Yoh T; Seo S
    Ann Surg Oncol; 2020 Jun; 27(6):1918. PubMed ID: 32170479
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Age Is an Important Determinant of Concordance Between 21-Gene Recurrence Scores in Multiple Ipsilateral Breast Carcinomas.
    Pawloski KR; Tadros AB; El-Tamer M
    Ann Surg Oncol; 2021 Aug; 28(8):4263-4264. PubMed ID: 33415560
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Routine Radiologic Staging of Distant Metastases Must Be Recommended as a Binding Guideline After Diagnosis of Local Breast Cancer Recurrence.
    Güth U
    Ann Surg Oncol; 2019 Oct; 26(11):3462-3463. PubMed ID: 31313032
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.
    Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?
    Osterman E; Glimelius B
    Ann Surg Oncol; 2020 Apr; 27(4):1046-1047. PubMed ID: 31884560
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors.
    Folkert IW; Roses RE
    Ann Surg Oncol; 2020 Mar; 27(3):864-865. PubMed ID: 31749081
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Clinical Implication of Nomograms in the Breast Oncology Field.
    Corso G
    Ann Surg Oncol; 2020 Jun; 27(6):1875-1876. PubMed ID: 32103418
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence.
    Sawaki M; Kodaira T; Iwata H
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):660-661. PubMed ID: 31359282
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
    Malleo G; Maggino L; Fernàndez-Del Castillo C; Salvia R
    Ann Surg Oncol; 2020 Oct; 27(10):3913-3914. PubMed ID: 32399766
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer.
    Kroese TE; van Rossum PSN; van Hillegersberg R
    Ann Surg Oncol; 2022 Aug; 29(8):4858-4860. PubMed ID: 35307806
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: A Genomic Blood Test (NETest) that Informs you if the Patient has a Recurrence at the First Postoperative Visit.
    Modlin IM
    Ann Surg Oncol; 2021 Nov; 28(12):7518-7519. PubMed ID: 33876353
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
    Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
    Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.